News
Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are ...
Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...
WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.
A new kind of HIV prevention is making it easier for those at risk to stay protected, thanks to a twice-yearly injection now ...
PEPFAR was launched in 2003 to stop the spread of HIV in Africa. Now, although some funding remains for the program, many of ...
Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
Lenacapavir, new twice-yearly HIV injection, raises hope for pill-weary patients. Discordant couples, sex workers hail ‘game ...
Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...
The World Health Organization has suggested global release of lenacapavir, a twice-yearly injectable medication, as a powerful HIV infection-fighting medication. The historic suggestion was made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results